Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

23,506 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.
Yu H, Kortylewski M, Pardoll D. Yu H, et al. Nat Rev Immunol. 2007 Jan;7(1):41-51. doi: 10.1038/nri1995. Nat Rev Immunol. 2007. PMID: 17186030 Review.
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.
Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Niu G, et al. Among authors: yu h. Oncogene. 2002 Mar 27;21(13):2000-8. doi: 10.1038/sj.onc.1205260. Oncogene. 2002. PMID: 11960372
Roles of activated Src and Stat3 signaling in melanoma tumor cell growth.
Niu G, Bowman T, Huang M, Shivers S, Reintgen D, Daud A, Chang A, Kraker A, Jove R, Yu H. Niu G, et al. Among authors: yu h. Oncogene. 2002 Oct 10;21(46):7001-10. doi: 10.1038/sj.onc.1205859. Oncogene. 2002. PMID: 12370822
Combination therapy with AG-490 and interleukin 12 achieves greater antitumor effects than either agent alone.
Burdelya L, Catlett-Falcone R, Levitzki A, Cheng F, Mora LB, Sotomayor E, Coppola D, Sun J, Sebti S, Dalton WS, Jove R, Yu H. Burdelya L, et al. Among authors: yu h. Mol Cancer Ther. 2002 Sep;1(11):893-9. Mol Cancer Ther. 2002. PMID: 12481410
A critical role for Stat3 signaling in immune tolerance.
Cheng F, Wang HW, Cuenca A, Huang M, Ghansah T, Brayer J, Kerr WG, Takeda K, Akira S, Schoenberger SP, Yu H, Jove R, Sotomayor EM. Cheng F, et al. Among authors: yu h. Immunity. 2003 Sep;19(3):425-36. doi: 10.1016/s1074-7613(03)00232-2. Immunity. 2003. PMID: 14499117
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells.
Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. Wang T, et al. Among authors: yu h. Nat Med. 2004 Jan;10(1):48-54. doi: 10.1038/nm976. Epub 2003 Dec 21. Nat Med. 2004. PMID: 14702634
The STATs of cancer--new molecular targets come of age.
Yu H, Jove R. Yu H, et al. Nat Rev Cancer. 2004 Feb;4(2):97-105. doi: 10.1038/nrc1275. Nat Rev Cancer. 2004. PMID: 14964307 Review. No abstract available.
Inhibition of constitutive signal transducer and activator of transcription 3 activation by novel platinum complexes with potent antitumor activity.
Turkson J, Zhang S, Palmer J, Kay H, Stanko J, Mora LB, Sebti S, Yu H, Jove R. Turkson J, et al. Among authors: yu h. Mol Cancer Ther. 2004 Dec;3(12):1533-42. Mol Cancer Ther. 2004. PMID: 15634646
Stat3 activity in melanoma cells affects migration of immune effector cells and nitric oxide-mediated antitumor effects.
Burdelya L, Kujawski M, Niu G, Zhong B, Wang T, Zhang S, Kortylewski M, Shain K, Kay H, Djeu J, Dalton W, Pardoll D, Wei S, Yu H. Burdelya L, et al. Among authors: yu h. J Immunol. 2005 Apr 1;174(7):3925-31. doi: 10.4049/jimmunol.174.7.3925. J Immunol. 2005. PMID: 15778348 Free PMC article.
Targeting STAT3 affects melanoma on multiple fronts.
Kortylewski M, Jove R, Yu H. Kortylewski M, et al. Among authors: yu h. Cancer Metastasis Rev. 2005 Jun;24(2):315-27. doi: 10.1007/s10555-005-1580-1. Cancer Metastasis Rev. 2005. PMID: 15986140 Review.
23,506 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback